The Bee Sting That Was Not: An Unusual Case of Hymenoptera Anaphylaxis Averted in a Patient Treated with Omalizumab for Asthma
This paper presents a case of hymenoptera venom anaphylaxis averted by omalizumab, a monoclonal antibody to IgE antibody. This case suggests a novel and unintentional effect of this therapy. Currently omalizumab is only FDA approved for the treatment of moderate-persistent allergic asthma. Howeve...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | Case Reports in Medicine |
| Online Access: | http://dx.doi.org/10.1155/2014/138963 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832564357974720512 |
|---|---|
| author | Evelyn M. Slaughter Nathan Boyer Steven Bennett |
| author_facet | Evelyn M. Slaughter Nathan Boyer Steven Bennett |
| author_sort | Evelyn M. Slaughter |
| collection | DOAJ |
| description | This paper presents a case of hymenoptera venom anaphylaxis averted by omalizumab, a monoclonal antibody to IgE antibody. This case suggests a novel and unintentional effect of this therapy. Currently omalizumab is only FDA approved for the treatment of moderate-persistent allergic asthma. However case reports, such as ours have illustrated omalizumab’s efficacy in the treatment of a myriad immunologic and allergic diseases. These outcomes have broadened the understanding of omalizumab’s complex mechanism of action. |
| format | Article |
| id | doaj-art-c85a44096b164c31a355367ee46c042b |
| institution | Kabale University |
| issn | 1687-9627 1687-9635 |
| language | English |
| publishDate | 2014-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Medicine |
| spelling | doaj-art-c85a44096b164c31a355367ee46c042b2025-02-03T01:11:14ZengWileyCase Reports in Medicine1687-96271687-96352014-01-01201410.1155/2014/138963138963The Bee Sting That Was Not: An Unusual Case of Hymenoptera Anaphylaxis Averted in a Patient Treated with Omalizumab for AsthmaEvelyn M. Slaughter0Nathan Boyer1Steven Bennett2Department of Internal Medicine, Madigan Army Medical Center, 9040 Fitzsimmons Drive, Tacoma, WA 98431, USADepartment of Pulmonary and Critical Care Medicine, Brooke Army Medical Center, 3851 Roger Brooke Drive No. 3600, San Antonio, TX 78219, USADepartment of Pulmonary, Sleep and Critical Care Medicine, Madigan Army Medical Center, 9040 Fitzsimmons Drive, Tacoma, WA 98431, USAThis paper presents a case of hymenoptera venom anaphylaxis averted by omalizumab, a monoclonal antibody to IgE antibody. This case suggests a novel and unintentional effect of this therapy. Currently omalizumab is only FDA approved for the treatment of moderate-persistent allergic asthma. However case reports, such as ours have illustrated omalizumab’s efficacy in the treatment of a myriad immunologic and allergic diseases. These outcomes have broadened the understanding of omalizumab’s complex mechanism of action.http://dx.doi.org/10.1155/2014/138963 |
| spellingShingle | Evelyn M. Slaughter Nathan Boyer Steven Bennett The Bee Sting That Was Not: An Unusual Case of Hymenoptera Anaphylaxis Averted in a Patient Treated with Omalizumab for Asthma Case Reports in Medicine |
| title | The Bee Sting That Was Not: An Unusual Case of Hymenoptera Anaphylaxis Averted in a Patient Treated with Omalizumab for Asthma |
| title_full | The Bee Sting That Was Not: An Unusual Case of Hymenoptera Anaphylaxis Averted in a Patient Treated with Omalizumab for Asthma |
| title_fullStr | The Bee Sting That Was Not: An Unusual Case of Hymenoptera Anaphylaxis Averted in a Patient Treated with Omalizumab for Asthma |
| title_full_unstemmed | The Bee Sting That Was Not: An Unusual Case of Hymenoptera Anaphylaxis Averted in a Patient Treated with Omalizumab for Asthma |
| title_short | The Bee Sting That Was Not: An Unusual Case of Hymenoptera Anaphylaxis Averted in a Patient Treated with Omalizumab for Asthma |
| title_sort | bee sting that was not an unusual case of hymenoptera anaphylaxis averted in a patient treated with omalizumab for asthma |
| url | http://dx.doi.org/10.1155/2014/138963 |
| work_keys_str_mv | AT evelynmslaughter thebeestingthatwasnotanunusualcaseofhymenopteraanaphylaxisavertedinapatienttreatedwithomalizumabforasthma AT nathanboyer thebeestingthatwasnotanunusualcaseofhymenopteraanaphylaxisavertedinapatienttreatedwithomalizumabforasthma AT stevenbennett thebeestingthatwasnotanunusualcaseofhymenopteraanaphylaxisavertedinapatienttreatedwithomalizumabforasthma AT evelynmslaughter beestingthatwasnotanunusualcaseofhymenopteraanaphylaxisavertedinapatienttreatedwithomalizumabforasthma AT nathanboyer beestingthatwasnotanunusualcaseofhymenopteraanaphylaxisavertedinapatienttreatedwithomalizumabforasthma AT stevenbennett beestingthatwasnotanunusualcaseofhymenopteraanaphylaxisavertedinapatienttreatedwithomalizumabforasthma |